查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1279776

2022-2029年全球骨關節炎治療藥物市場規模研究與預測，按藥物類型分析，按配銷通路和區域分析

Global Osteoarthritis Therapeutics Market Size study & Forecast, by Anatomy by Drug Type, by Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021年全球骨關節炎治療藥物市場價值約為7.34846億美元，預計在2022-2029年預測期內將以超過8.8%的健康增長率增長。骨關節炎是最普遍的慢性健康疾病之一，其特徵是持續疼痛、損傷和活動能力下降。這是一種關節退行性疾病，隨著時間的推移而惡化，並且是由一個或多個關節中軟骨的惡化和最終損失引起的。軟骨的一個例子是存在於骨骼之間的關節，包括膝關節、踝關節和肘關節。它有助於潤滑關節和降低摩擦。骨關節炎的治療旨在減少疼痛和改善功能狀態。由於骨關節炎的發病率越來越高，以及易受骨關節炎影響的人口越來越多等因素，骨關節炎治療市場正在擴大。

根據美國疾病控制和預防中心的數據，在2020年，美國約有6300萬人被診斷患有關節炎，預計到2045年將達到7800萬人。因此，骨關節炎發病率的上升正在推動市場的增長。歐洲臨床醫學雜誌》在2020年指出，全世界40歲以上的人中大約有22%被診斷為膝關節骨性關節炎。根據世界銀行集團的數據，2020年世界老齡人口為7.27億，預計在未來30年將增加三倍，在2050年達到15億。因此，該地區老年人口的增加進一步推動了市場的增長。此外，運動損傷數量的增加和治療骨關節炎的個性化藥物的開發正在為市場創造一個有利的增長。然而，在骨關節炎治療中使用非甾體抗炎藥的不良心血管事件風險和替代品的商業化可能會阻礙市場增長。

全球骨關節炎治療藥物市場研究涵蓋的主要地區包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於主要市場參與者的主導地位和該地區日益增長的疾病流行率，北美在收入方面主導了市場。而亞太地區在預測期內預計將以最高的複合年增長率增長，原因是老年病和目標人群的增加，產品開發合作的數量增加，主要參與者的地理擴張，以及政府和非營利組織對市場空間的積極參與等因素。

該研究的目的是定義近年來不同市場區隔和國家的市場規模，並預測未來幾年的價值。該報告旨在涵蓋參與研究的國家/地區的該行業的定性和定量方面。

該報告還提供了關於關鍵方面的詳細資訊，如驅動因素和挑戰，這將確定市場的未來增長。此外，它還涵蓋了微觀市場的潛在機會，供利益相關者投資，以及對競爭格局和主要參與者的分析產品的詳細分析。 .

目錄

第一章：執行摘要

  • 市場簡介
  • 2019-2029年全球及細分市場的估計和預測
    • 2019-2029年，按地區分類的骨關節炎治療劑市場
    • 2019-2029年骨關節炎治療法市場，按解剖學分類
    • 2019-2029年，按藥物類型分類，骨關節炎治療市場
    • 2019-2029年，按配銷通路分類，骨關節炎治療市場
  • 主要趨勢
  • 估算方法
  • 研究假設

第二章：全球骨關節炎治療藥物市場的定義和範圍

  • 本研究的目的
  • 市場定義和範圍
    • 研究的範圍
    • 行業演變
  • 研究涵蓋的年份
  • 貨幣兌換率

第三章：全球骨關節炎治療劑市場動態

  • 骨關節炎治療劑市場影響分析（2019-2029年）
    • 市場驅動力
      • 骨關節炎的發病率不斷增加
      • 易受骨關節炎影響的人口不斷增加
    • 市場挑戰
      • 與使用非甾體抗炎藥有關的不良心血管事件的風險
      • 替代品的商業化
    • 市場機會
      • 運動傷害的數量不斷增加
      • 個人化藥物的開發

第四章：全球骨關節炎治療藥物市場行業分析

  • 波特五力模型
    • 供應商的議價能力
    • 買方的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭性的競爭
  • 波特五力模型的未來方法（2019-2029年）
  • PEST分析
    • 政治因素
    • 經濟
    • 社會
    • 技術
  • 最佳投資機會
  • 最佳策略
  • 行業專家展望
  • 分析師建議和結論

第五章：風險評估：COVID-19的影響

  • 評估COVID-19對行業的整體影響
  • COVID-19前和COVID-19後的市場情況

第六章：全球骨關節炎治療藥物市場，按解剖學分類

  • 市場簡介
  • 全球骨關節炎治療劑市場，按解剖學分類，性能-潛力分析
  • 2019-2029年全球骨關節炎治療劑市場按解剖學的估計和預測
  • 骨關節炎治療劑市場，細項分析
    • 膝關節骨性關節炎
    • 髖關節骨關節炎
    • 手部骨關節炎
    • 小關節骨關節炎

第7章：全球骨關節炎治療藥物市場，按藥物類型分類

  • 市場簡介
  • 按藥物類型分類的全球骨關節炎治療劑市場，表現- 潛力分析
  • 2019-2029年全球骨關節炎治療劑市場按藥物類型的估計和預測
  • 骨關節炎治療劑市場，細項分析
    • 粘液補充劑
    • 非甾體類抗炎藥
    • 鎮痛劑
    • 皮質類固醇

第八章：全球骨關節炎治療藥物市場，按配銷通路分類

  • 市場簡介
  • 按配銷通路分類的全球骨關節炎治療劑市場，表現- 潛力分析
  • 2019-2029年全球骨關節炎治療劑市場按配銷通路的估計和預測
  • 骨關節炎治療劑市場，細項分析
    • 醫院藥房
    • 零售藥店
    • 網上藥店

第九章：全球骨關節炎治療藥物市場，區域分析

  • 骨關節炎治療藥物市場，區域市場簡介
  • 北美洲
    • 美國
      • 2019-2029年解剖學分類估計和預測
      • 2019-2029年藥物類型細分估計和預測
      • 2019-2029年，配銷通路的細分估計和預測
    • 加拿大
  • 歐洲骨關節炎治療藥物市場簡介
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區骨關節炎治療藥物市場簡介
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 亞太其他地區
  • 拉丁美洲骨關節炎治療藥物市場簡介
    • 巴西
    • 墨西哥
    • 拉美其他地區
  • 世界其他地區

第十章：競爭情報

  • 頂級市場戰略
  • 公司簡介
    • Pfizer, Inc
      • 關鍵資訊
      • 概況
      • 財務（取決於數據的可用性）
      • 產品摘要
      • 近期發展情況
    • Eli Lilly and Company
    • Horizon Therapeutics plc
    • Ferring BV
    • Merck Sharp & Dohme Corp.
    • GlaxoSmithKline Plc.
    • Johnson & Johnson Private Limited
    • Bayer AG
    • Novartis AG
    • Pacira Pharmaceuticals, Inc

第十一章：研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 研究屬性
  • 研究假設

Global Osteoarthritis Therapeutics Market is valued approximately USD 7348.46 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.8% over the forecast period 2022-2029. One of the most prevalent chronic health disorders, osteoarthritis is characterised by persistent pain, impairment, and decreased mobility. It is a degenerative condition of the joints that worsens with time and is brought on by the deterioration and eventual loss of cartilage in one or more joints. An example of cartilage is present in the joints between bones include the knee, ankle, and elbow. It assists in lubricating the joint and lowering friction. Treatment for osteoarthritis aims to reduce pain and improve functional status. The Osteoarthritis Therapeutics market is expanding because of factors such as Increasing prevalence of osteoarthritis and Growing population susceptible to osteoarthritis.

According to Centers for Disease Control and Prevention, in year 2020, there were around 63 million people in US had diagnosed with arthritis which is expected to reach at 78 million by year 2045. Thus rising prevelance of osteoarthritis is propelling the market growth. The Journal of EClinical Medicine stated in 2020 that roughly 22% of people over 40 years of age worldwide have been diagnosed with knee osteoarthritis. According to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Thus rising geriatric population in the region is further escalating the market growth. In addition, Rising number of sports injuries and development of Personalized medicines for osteoarthritis is creating a lucrative growth to the market. However, Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment and Commercialization of alternatives may hamper the market growth.

The key regions considered for the Global Osteoarthritis Therapeutics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of key market players and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Pfizer, Inc
  • Eli Lilly and Company
  • Horizon Therapeutics plc
  • Ferring B.V.
  • Merck Sharp & Dohme Corp.
  • GlaxoSmithKline Plc.
  • Johnson & Johnson Private Limited
  • Bayer AG
  • Novartis AG
  • Pacira Pharmaceuticals, Inc

Recent Developments in the Market:

  • In January 2023, Arugula Sciences, LLC announced that it had received FDA permission for a Phase 1 clinical trial in the US for its first therapeutic product, Signature Cord PrimeTM. This was accomplished in partnership with its clinical partners. For patients with symptomatic knee osteoarthritis, this Phase 1 research is an open-label, dosage-ranging evaluation of safety, tolerability, preliminary effectiveness, and dose effects.
  • In February 2022, Alkem Laboratories announced that the Drug Controller General of India (DCGI) had approved the marketing of StemOne in India. The product is suggested for a variety of conditions, including knee osteoarthritis. It is the first allogeneic cell therapy product to be given commercial approval in India for the treatment of osteoarthritis of the knee.

Global Osteoarthritis Therapeutics Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Anatomy, Drug Type, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Anatomy offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Anatomy:

  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Hand Osteoarthritis
  • Small Joint Osteoarthritis

By Drug Type:

  • Viscosupplementation Agents
  • Non-steroidal Anti-inflammatory Drugs
  • Analgesics
  • Corticosteroids

By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Osteoarthritis Therapeutics Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Osteoarthritis Therapeutics Market, by Anatomy , 2019-2029 (USD Million)
    • 1.2.3. Osteoarthritis Therapeutics Market, by Drug Type, 2019-2029 (USD Million)
    • 1.2.4. Osteoarthritis Therapeutics Market, by Distribution Channel, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Osteoarthritis Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Osteoarthritis Therapeutics Market Dynamics

  • 3.1. Osteoarthritis Therapeutics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of osteoarthritis
      • 3.1.1.2. Growing population susceptible to osteoarthritis
    • 3.1.2. Market Challenges
      • 3.1.2.1. Risk of adverse cardiovascular events associated with the use of NSAIDs
      • 3.1.2.2. Commercialization of alternatives
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising number of sports injuries
      • 3.1.3.2. Development of Personalized medicines

Chapter 4. Global Osteoarthritis Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Osteoarthritis Therapeutics Market, by Anatomy

  • 6.1. Market Snapshot
  • 6.2. Global Osteoarthritis Therapeutics Market by Anatomy , Performance - Potential Analysis
  • 6.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Anatomy 2019-2029 (USD Million)
  • 6.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
    • 6.4.1. Knee Osteoarthritis
    • 6.4.2. Hip Osteoarthritis
    • 6.4.3. Hand Osteoarthritis
    • 6.4.4. Small Joint Osteoarthritis

Chapter 7. Global Osteoarthritis Therapeutics Market, by Drug Type

  • 7.1. Market Snapshot
  • 7.2. Global Osteoarthritis Therapeutics Market by Drug Type, Performance - Potential Analysis
  • 7.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Drug Type 2019-2029 (USD Million)
  • 7.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Viscosupplementation Agents
    • 7.4.2. Non-steroidal Anti-inflammatory Drugs
    • 7.4.3. Analgesics
    • 7.4.4. Corticosteroids

Chapter 8. Global Osteoarthritis Therapeutics Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Osteoarthritis Therapeutics Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Osteoarthritis Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
  • 8.4. Osteoarthritis Therapeutics Market, Sub Segment Analysis
    • 8.4.1. Hospitals Pharmacies
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Online Pharmacies

Chapter 9. Global Osteoarthritis Therapeutics Market, Regional Analysis

  • 9.1. Osteoarthritis Therapeutics Market, Regional Market Snapshot
  • 9.2. North America Osteoarthritis Therapeutics Market
    • 9.2.1. U.S. Osteoarthritis Therapeutics Market
      • 9.2.1.1. Anatomy breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Drug Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Osteoarthritis Therapeutics Market
  • 9.3. Europe Osteoarthritis Therapeutics Market Snapshot
    • 9.3.1. U.K. Osteoarthritis Therapeutics Market
    • 9.3.2. Germany Osteoarthritis Therapeutics Market
    • 9.3.3. France Osteoarthritis Therapeutics Market
    • 9.3.4. Spain Osteoarthritis Therapeutics Market
    • 9.3.5. Italy Osteoarthritis Therapeutics Market
    • 9.3.6. Rest of Europe Osteoarthritis Therapeutics Market
  • 9.4. Asia-Pacific Osteoarthritis Therapeutics Market Snapshot
    • 9.4.1. China Osteoarthritis Therapeutics Market
    • 9.4.2. India Osteoarthritis Therapeutics Market
    • 9.4.3. Japan Osteoarthritis Therapeutics Market
    • 9.4.4. Australia Osteoarthritis Therapeutics Market
    • 9.4.5. South Korea Osteoarthritis Therapeutics Market
    • 9.4.6. Rest of Asia Pacific Osteoarthritis Therapeutics Market
  • 9.5. Latin America Osteoarthritis Therapeutics Market Snapshot
    • 9.5.1. Brazil Osteoarthritis Therapeutics Market
    • 9.5.2. Mexico Osteoarthritis Therapeutics Market
    • 9.5.3. Rest of Latin America Osteoarthritis Therapeutics Market
  • 9.6. Rest of The World Osteoarthritis Therapeutics Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Pfizer, Inc
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Eli Lilly and Company
    • 10.2.3. Horizon Therapeutics plc
    • 10.2.4. Ferring B.V.
    • 10.2.5. Merck Sharp & Dohme Corp.
    • 10.2.6. GlaxoSmithKline Plc.
    • 10.2.7. Johnson & Johnson Private Limited
    • 10.2.8. Bayer AG
    • 10.2.9. Novartis AG
    • 10.2.10. Pacira Pharmaceuticals, Inc

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Osteoarthritis Therapeutics Market, report scope
  • TABLE 2. Global Osteoarthritis Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Osteoarthritis Therapeutics Market estimates & forecasts by Anatomy 2019-2029 (USD Million)
  • TABLE 4. Global Osteoarthritis Therapeutics Market estimates & forecasts by Drug Type 2019-2029 (USD Million)
  • TABLE 5. Global Osteoarthritis Therapeutics Market estimates & forecasts by Distribution Channel 2019-2029 (USD Million)
  • TABLE 6. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Osteoarthritis Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. Global Osteoarthritis Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. U.S. Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 17. U.S. Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 18. U.S. Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. Canada Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 20. Canada Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 21. Canada Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. UK Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 23. UK Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 24. UK Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. Germany Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 26. Germany Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 27. Germany Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. France Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 29. France Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 30. France Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. Italy Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 32. Italy Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 33. Italy Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Spain Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 35. Spain Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 36. Spain Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. RoE Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 38. RoE Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 39. RoE Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. China Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 41. China Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 42. China Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. India Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 44. India Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 45. India Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. Japan Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 47. Japan Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 48. Japan Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. South Korea Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 50. South Korea Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 51. South Korea Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. Australia Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 53. Australia Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 54. Australia Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. RoAPAC Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 57. RoAPAC Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. Brazil Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 59. Brazil Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 60. Brazil Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Mexico Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 62. Mexico Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 63. Mexico Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. RoLA Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 65. RoLA Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 66. RoLA Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. Row Osteoarthritis Therapeutics Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 68. Row Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 69. Row Osteoarthritis Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 70. List of secondary sources, used in the study of global Osteoarthritis Therapeutics Market
  • TABLE 71. List of primary sources, used in the study of global Osteoarthritis Therapeutics Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Osteoarthritis Therapeutics Market, research methodology
  • FIG 2. Global Osteoarthritis Therapeutics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Osteoarthritis Therapeutics Market, key trends 2021
  • FIG 5. Global Osteoarthritis Therapeutics Market, growth prospects 2022-2029
  • FIG 6. Global Osteoarthritis Therapeutics Market, porters 5 force model
  • FIG 7. Global Osteoarthritis Therapeutics Market, pest analysis
  • FIG 8. Global Osteoarthritis Therapeutics Market, value chain analysis
  • FIG 9. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Osteoarthritis Therapeutics Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Osteoarthritis Therapeutics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
  • FIG 17. Asia pacific Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Osteoarthritis Therapeutics Market 2019 & 2029 (USD Million)
  • FIG 19. Global Osteoarthritis Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable